Seq_ID,Species,Phylogenetic lineage,Predicted drug resistance,Rifampicin,Isoniazid,Pyrazinamide,Ethambutol,Moxifloxacin,Amikacin,Cycloserine,Ethionamide,Kanamycin,Streptomycin,Capreomycin,Para-aminosalicylic acid,Clofazimine,Delamanid,Bedaquiline,Linezolid,Median genome coverage,Percentage reads mapped,Quality,Database version
Q,Mycobacterium tuberculosis,Lineage 2,Pre-Extensive/Extensive drug-resistance predicted,rpoC_p.Ile491Thr (Resistant|Uncertain);rpoB_p.Ser450Leu (Resistant|High),fabG1_c.-15C>T (Low-level resistant|High);katG_p.Tyr155Ser (Resistant|Uncertain),pncA_p.Val139Ala (Resistant|High),embB_p.Asp1024Asn (Resistant|Uncertain);embB_p.Met306Val (Resistant|High),gyrA_p.Ser91Pro (Resistant|High);gyrA_p.Ala90Val (Resistant only in combination|High),No mechanism identified,No mechanism identified,fabG1_c.-15C>T (Resistant|High),No mechanism identified,rpsL_p.Lys88Arg (Resistant|High),No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,177,98.91,Pass QC,tbtamr_2022-12-02
